T De Pas R Danesi C Catania G Curigliano F De Braud Italia Sarcoma Group
10.1038/sj.bjc.6601282
Br J Cancer
2003 Oct 20;89(8):1403-4.
CC BY
https://pubmed.ncbi.nlm.nih.gov/14562006/
Antineoplastic Agents / pharmacology Gastrointestinal Neoplasms / pathology Jaundice / etiology Liver Neoplasms / complications Liver Neoplasms / secondary Piperazines / pharmacology Pyrimidines / pharmacology
Antineoplastic Agents / pharmacology Gastrointestinal Neoplasms / pathology Jaundice / etiology Liver Neoplasms / complications Liver Neoplasms / secondary Piperazines / pharmacology Pyrimidines / pharmacology Case Reports Adult Aged Antineoplastic Agents / administration & dosage Antineoplastic Agents / adverse effects Benzamides Female Gastrointestinal Neoplasms / complications Humans Imatinib Mesylate Male Piperazines / administration & dosage Piperazines / adverse effects Pyrimidines / administration & dosage Pyrimidines / adverse effects Stromal Cells / pathology Treatment Outcome Antineoplastic Agents Benzamides Piperazines Pyrimidines Imatinib Mesylate
PMC2394355
14562006
Imatinib administration in two patients with liver metastases from GIST and severe jaundice
2003